Details of the Drug Formulaction

General Information of Drug Formulation (ID: F20943)

• Formulation Name: Terazosin 2 mg capsule
• Company: Aidarex Pharmaceuticals; Apotex

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Terazosin	(DM3JCVS)	Benign prostatic hyperplasia	GA90	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Allura red AC dye	(E00338)	33258	Colorant
Ammonia	(E00007)	222	Alkalizing agent
Ferrosoferric oxide	(E00231)	14789	Colorant
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Potassium hydroxide	(E00233)	14797	Alkalizing agent
Propylene glycol	(E00040)	1030	Antimicrobial preservative; Humectant; Plasticizing agent; Solvent
Quinoline yellow WS	(E00309)	24671	Colorant
Stearic acid	(E00079)	5281	Emulsifying agent; Solubilizing agent; Viscosity-controlling agent; lubricant
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent